ACADIA PHARMACEUTICALS INC - COM (ACAD)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
155M
Holdings value Q3 2024
$2.38B
Value change Q3 2024
-$122M
Grand Portfolio weight change Q3 2024
0%
Number of holders
255
Number of buys Q3 2024
118
Number of sells Q3 2024
-125
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 155M $2.38B -$122M $15.38 257
2024 Q2 161M $2.62B +$12.3M $16.25 265
2024 Q1 160M $2.95B -$55.7M $18.49 267
2023 Q4 159M $4.99B +$184M $31.31 275
2023 Q3 155M $3.23B -$113M $20.84 246
2023 Q2 159M $3.81B +$45.6M $23.95 235
2023 Q1 158M $2.97B +$53.4M $18.82 231
2022 Q4 156M $2.48B +$28.8M $15.92 220
2022 Q3 152M $2.49B +$31.6M $16.36 213
2022 Q2 150M $2.12B +$730K $14.09 231
2022 Q1 147M $3.56B -$19.7M $24.22 254
2021 Q4 148M $3.46B +$79.7M $23.34 243
2021 Q3 145M $2.4B -$85.7M $16.61 224
2021 Q2 148M $3.61B +$54.4M $24.39 237
2021 Q1 145M $3.74B -$222M $25.80 260
2020 Q4 148M $7.9B -$102M $53.46 297
2020 Q3 150M $6.18B -$101M $41.25 263
2020 Q2 153M $7.39B -$42M $48.47 292
2020 Q1 154M $6.49B +$187M $42.25 244
2019 Q4 149M $6.39B +$119M $42.78 273
2019 Q3 146M $5.27B +$306M $35.99 231
2019 Q2 138M $3.69B +$147M $26.73 198
2019 Q1 138M $3.7B -$452K $26.85 198
2018 Q4 139M $2.25B +$303M $16.17 176
2018 Q3 120M $2.49B +$111M $20.76 183
2018 Q2 117M $1.78B -$138M $15.27 182
2018 Q1 122M $2.74B +$37.3M $22.47 193
2017 Q4 120M $3.61B +$37.1M $30.11 210
2017 Q3 118M $4.44B -$56.1M $37.67 207
2017 Q2 120M $3.34B +$82.5M $27.89 197
2017 Q1 119M $4.11B +$168M $34.38 213
2016 Q4 121M $3.49B +$86.1M $28.84 218
2016 Q3 118M $3.75B +$223M $31.81 227
2016 Q2 110M $3.59B +$18.7M $32.46 222
2016 Q1 110M $3.07B +$338M $27.96 208
2015 Q4 97.4M $3.47B -$45.9M $35.65 209
2015 Q3 98.5M $3.26B +$13.5M $33.07 183
2015 Q2 98.2M $4.12B +$66M $41.88 187
2015 Q1 97.3M $3.17B +$38.3M $32.59 193
2014 Q4 96.3M $3.06B +$57.8M $31.75 182
2014 Q3 94.2M $2.33B -$12.1M $24.76 162
2014 Q2 95M $2.15B +$59.7M $22.59 160
2014 Q1 90.9M $2.21B +$190M $24.33 163